Publikationen der ALS-Forschungsgruppe an der Charité
Neurofilament light chain (NfL) – Biomarker für die ALS-Progression
Meyer T, Salkic E, Grehl T, Weyen U, Kettemann D, Weydt P,
Der Einsatz von Patient-reported Outcome Measures (PROM) und die Perspektive digitaler Biomarker bei der Amyotrophen Lateralsklerose
Maier A, Münch C, Meyer T. Klinische Neurophysiologie 2023; 54(01): 28-34. doi:
Acceptance of Enhanced Robotic Assistance Systems in People With Amyotrophic Lateral Sclerosis-Associated Motor Impairment: Observational Online Study
Maier A, Eicher C, Kiselev J, Klebbe R, Greuèl M, Kettemann D,
Remote digital assessment of amyotrophic lateral sclerosis functional rating scale – a multicenter observational study
Meyer T, Spittel S, Grehl T, Weyen U, Steinbach R, Kettemann D,
Use and subjective experience of the impact of motor-assisted movement exercisers in people with amyotrophic lateral sclerosis: a multicenter observational study
Maier A, Gaudlitz M, Grehl T, Weyen U, Steinbach R, Grosskreutz J,
Non-invasive and tracheostomy invasive ventilation in amyotrophic lateral sclerosis: Utilization and survival rates in a cohort study over 12 years in Germany
Spittel S, Maier A, Kettemann D, Walter B, Koch B, Krause K,
Publikationen mit Beteiligung der ALS-Forschungsgruppe an der Charité
Effect of High-Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Ludolph AC, Dorst J, Dreyhaupt J,
Prognostic factors in ALS: a comparison between Germany and China
Dorst J, Chen L, Rosenbohm A,
GABA B receptor encephalitis in a patient diagnosed with amyotrophic lateral sclerosis
Schumacher H, Meyer T, Prüss H.
Comprehensive analysis of the mutation spectrum in 301 German ALS families
Müller K, Brenner D, Weydt P,
Therapeutic decision in ALS patients: cross-cultural differences and clinical implications
Andersen PM, Kuzma-Kozakiewicz M, Keller J,
The metabolic and endocrine characteristics in spinal and bulbar muscular atrophy
Rosenbohm A, Hirsch S, Volk AE,
Hot-spot KIF5A mutations cause familial ALS
Brenner D, Yilmaz R, Müller K,
July 2017 ENCALS statement on edaravone
Al-Chalabi A, Andersen PM, Chandran S,
Genome-wide association analysis identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis
van Rheenen W, Shatunov A, Dekker
